P, E. S., MM, C., KM, C., EM, D., G, D., HW, F., . . . NH, K. (2026). Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies). Drugs - real world outcomes, 13(1), 85. https://doi.org/10.1007/s40801-025-00536-4
Chicago Style (17th ed.) CitationP, Escribano Subias, et al. "Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes Across Baseline Risk Strata (SPHERE and EXPOSURE Studies)." Drugs - Real World Outcomes 13, no. 1 (2026): 85. https://doi.org/10.1007/s40801-025-00536-4.
MLA (9th ed.) CitationP, Escribano Subias, et al. "Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes Across Baseline Risk Strata (SPHERE and EXPOSURE Studies)." Drugs - Real World Outcomes, vol. 13, no. 1, 2026, p. 85, https://doi.org/10.1007/s40801-025-00536-4.